BONH
AMRX icon

Bank of New Hampshire’s Amneal Pharmaceuticals AMRX Stock Holding History

Bank of New Hampshire’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Sell
711
-847
-54% -$11.6K ﹤0.01% 443
2026
Q1 		$19.4K Buy
+1,558
New +$20.9K ﹤0.01% 407

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bank of New Hampshire's AMRX Position: Q2 2026 in Review

Bank of New Hampshire reduced its Amneal Pharmaceuticals (AMRX) stake by 54% in Q2 2026, selling an estimated $11.6K and leaving 711 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Bank of New Hampshire first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $19.4K in Q1 2026. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Bank of New Hampshire held 711 shares of Amneal Pharmaceuticals worth $12.3K as of Q2 2026.
  • Bank of New Hampshire sold 847 Amneal Pharmaceuticals shares in Q2 2026, an estimated $11.6K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #443 holding.
  • Bank of New Hampshire first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Bank of New Hampshire's Amneal Pharmaceuticals position peaked at $19.4K in Q1 2026.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.